Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-01-23 Cai Veronica Controller Grant or award · Stock Option (Right to Buy) +12,000 12,000
2020-01-23 Levy Howard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +45,000 45,000
2020-01-23 USMAN NASSIM President & CEO Grant or award · Stock Option (Right to Buy) +115,000 115,000
2020-01-15 TETLOW SHARON Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-01-15 Ling Geoffrey M.D. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-01-02 Williams Eddie Director Grant or award +1,743 8,839
2020-01-02 LAWLOR AUGUSTINE Director Grant or award +3,166 15,608
2019-09-16 Cai Veronica Controller Grant or award · Stock Option (Right to Buy) +3,000 3,000

Page 17 of 17 · 328 trades